Kobayashi Pharmaceutical Co(KBYPF)
$39.470.00 (0.00%)
KBYPF
Kobayashi Pharmaceutical Co financials statements
$39.47
At close:0.00 (0.00%)
Kobayashi Pharmaceutical Co (KBYPF) Income Statement
6 Followers
Kobayashi Pharmaceutical Co Income Statement
Last quarter (Q2 2026), Kobayashi Pharmaceutical Co's total revenue was ¥37.08B, an increase of 1.85% from the same quarter last year. In Q2, Kobayashi Pharmaceutical Co's net income was ¥101.00M. See Kobayashi Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 165.74B | ¥ 165.60B | ¥ 173.46B | ¥ 166.26B | ¥ 155.25B | |
| ¥ 84.71B | ¥ 87.60B | ¥ 96.38B | ¥ 92.33B | ¥ 88.77B | |
| ¥ 69.79B | ¥ 62.74B | ¥ 70.60B | ¥ 65.66B | ¥ 62.71B | |
| Depreciation and Amortization | ¥ 8.74B | ¥ 8.02B | ¥ 6.06B | ¥ 5.36B | ¥ 4.83B |
| ¥ 12.52B | ¥ 21.96B | ¥ 33.65B | ¥ 33.33B | ¥ 32.49B | |
| ¥ 14.92B | ¥ 24.86B | ¥ 25.78B | ¥ 26.67B | ¥ 26.07B | |
| ¥ -11.18B | ¥ -10.95B | ¥ 1.78B | ¥ 1.28B | ¥ 1.57B | |
| ¥ 3.74B | ¥ 13.91B | ¥ 27.56B | ¥ 27.95B | ¥ 27.64B | |
| ¥ 3.66B | ¥ 10.07B | ¥ 20.34B | ¥ 20.02B | ¥ 19.71B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 49.18 | ¥ 135.42 | ¥ 268.16 | ¥ 259.61 | ¥ 252.35 |
| Diluted EPS | ¥ 49.18 | ¥ 135.42 | ¥ 268.16 | ¥ 259.59 | ¥ 252.35 |
| Weighted Average Shares Outstanding | 74.34M | 74.34M | 75.84M | 77.12M | 78.13M |
| Weighted Average Shares Outstanding (Diluted) | 74.34M | 74.34M | 75.84M | 77.13M | 78.13M |
Currency in JPY
